Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organoid ...
Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...
PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models ...
SEATTLE, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pluristyx, Inc. today announced the formation of the Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network ...
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J., Feb. 9, 2026 ...
NEW YORK--(BUSINESS WIRE)--Signet Therapeutics (“Signet”), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, today announced that the first ...
BOSTON & SHENZHEN, China--(BUSINESS WIRE)--Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug ...
The National Institutes of Health is continuing its mission to reduce the use of animals in drug testing by awarding $87 million in contracts to launch the Standardized Organoid Modeling (SOM) Center, ...
A human model of immune-driven liver injury Some drugs that pass early safety testing can still cause idiosyncratic drug-induced liver injury (iDILI)—a rare immune reaction that can lead to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results